ESCITALOPRAM Side Effects

7026602-4 | Urinary Incontinence
on Sep 20, 2010 Female patient from DENMARK , 60 years of age, weighting 121.3 lb, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: urinary incontinence (What is urinary incontinence?). Escitalopram dosage: 20 Mg (20 Mg,1 In 1 D),oral. During the same period patient was treated with NOIAFREN (CLOBAZAM) (TABLETS) (CLOBAZAM) (View Noiafren (clobazam) (tablets) (clobazam) Review and Noiafren (clobazam) (tablets) (clobazam) Label ), EUTIROX (LEVOTHYROXINE) (TABLETS) (LEVOTHYROXINE) (View Eutirox (levothyroxine) (tablets) (levothyroxine) Review and Eutirox (levothyroxine) (tablets) (levothyroxine) Label ), ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) (TABLETS) (ATORVASTATIN CA (View Atorvastatin Calcium (atorvastatin Calcium) (tablets) (atorvastatin Ca Review and Atorvastatin Calcium (atorvastatin Calcium) (tablets) (atorvastatin Ca Label ), OMEPRAZOLE (OMEPRAZOLE) (TABLETS) (OMEPRAZOLE) (View Omeprazole (omeprazole) (tablets) (omeprazole) Review and Omeprazole (omeprazole) (tablets) (omeprazole) Label ).

7026601-2 | Psychiatric Evaluation Abnormal
Patient was taking Escitalopram (View Usage). Patient had the following side effects: psychiatric evaluation abnormal on Sep 20, 2010 from DENMARK Additional patient health information: Female patient , 53 years of age, was diagnosed with depression (What is depression?) and. Escitalopram dosage: 10 Mg (10 Mg,1 In 1 D),oral.

7024461-7 | Dyskinesia, Muscle Contracture
Adverse event was reported on Sep 17, 2010 by a Female patient taking Escitalopram (View Usage) (Dosage: 10 Mg (10 Mg, 1 In 1 D), Oral) was diagnosed with depression (What is depression?) and. Location: DENMARK , 34 years of age, weighting 172.0 lb, After Escitalopram was administered, patient had the following side effects: dyskinesia, muscle contracture. During the same period patient was treated with MINIDRIL (EUGYNON) (EUGYNON) (View Minidril (eugynon) (eugynon) Review and Minidril (eugynon) (eugynon) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), SOLUPRED (PREDNISOLONE) (PREDNISOLONE) (View Solupred (prednisolone) (prednisolone) Review and Solupred (prednisolone) (prednisolone) Label ), PANOS (TETRAZEPAM) (TETRAZEPAM) (View Panos (tetrazepam) (tetrazepam) Review and Panos (tetrazepam) (tetrazepam) Label ).

7024432-0 | Blood Sodium Decreased, Depressed Level Of Consciousness, Hypoxia
on Sep 17, 2010 Female patient from DENMARK , 78 years of age, weighting 97.00 lb, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium decreased, depressed level of consciousness, hypoxia. Escitalopram dosage: 10 Mg (10 Mg, 1 In 1 D), Oral.


7024430-7 | Investigation Abnormal
on Sep 17, 2010 Female patient from DENMARK , 52 years of age, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient had the following side effects: investigation abnormal. Escitalopram dosage: Oral.

7024429-0 | Mental Disorder
Patient was taking Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: mental disorder on Sep 17, 2010 from DENMARK Additional patient health information: Female patient , 47 years of age, was diagnosed with depression (What is depression?) and. Escitalopram dosage: Oral.

7021598-3 | Nervousness
Adverse event was reported on Sep 16, 2010 by a Female patient taking Escitalopram (View Usage) (Dosage: 2.5 Mg (2.5 Mg, 1 In 1 D)) was diagnosed with major depression and. Location: DENMARK , 40 years of age, Patient experienced the following unwanted or unexpected effects: nervousness.

7020502-1 | Arthralgia, Gait Disturbance, Gamma-glutamyltransferase Increased, Inflammation, Myalgia, Spondylitis, Transaminases Increased
on Sep 16, 2010 Female patient from DENMARK , 56 years of age, weighting 176.4 lb, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient had the following side effects: arthralgia, gait disturbance, gamma-glutamyltransferase increased, inflammation, myalgia, spondylitis, transaminases increased. Escitalopram dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

7018540-8 | Cholestasis, Cytolytic Hepatitis
on Sep 10, 2010 Female patient from DENMARK , 67 years of age, was diagnosed with depression (What is depression?), hyperuricaemia, constipation (What is constipation?) and was treated with Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: cholestasis, cytolytic hepatitis. Escitalopram dosage: (1 Dosage Forms). During the same period patient was treated with CALCIPARINE (22500 Iu (7500 Iu, 3 In 1 D), Subcutaneous) (View Calciparine Review and Calciparine Label ), COLCHICINE (COLCHICINE) (1 Dosage Forms 91 Dosage Forms, 1 In 1 D), Oral) (View Colchicine (colchicine) Review and Colchicine (colchicine) Label ), FORLAX (MACROGOL) (10 GRAM) ((3 Dosage Forms)) (View Forlax (macrogol) (10 Gram) Review and Forlax (macrogol) (10 Gram) Label ), NORMACOL (View Normacol Review and Normacol Label ), KETOPROFEN ((2 Dosage Forms), Oral) (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

7018488-9 | Investigation Abnormal
Patient was taking Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: investigation abnormal on Sep 10, 2010 from DENMARK Additional patient health information: Female patient , 84 years of age, was diagnosed with depression (What is depression?) and. Escitalopram dosage: 5 Mg (5 Mg, 1 In 1 D), Oral.

7018432-4 | Vaginal Haemorrhage
Adverse event was reported on Sep 13, 2010 by a Female patient taking Escitalopram (View Usage) (Dosage: 10 Mg (10 Mg, 1 In 1 D), Oral) was diagnosed with depression (What is depression?) and. Location: DENMARK , 32 years of age, weighting 121.3 lb, Patient had the following side effects: vaginal haemorrhage. During the same period patient was treated with CYMBALTA (DULOXETINE HYDROCHLORIDE) (DULOXETINE HYDROCHLORIDE) (View Cymbalta (duloxetine Hydrochloride) (duloxetine Hydrochloride) Review and Cymbalta (duloxetine Hydrochloride) (duloxetine Hydrochloride) Label ).

7018250-7 | Confusional State, Hyponatraemia
on Sep 27, 2010 Female patient from UNITED STATES , 79 years of age, was treated with Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: confusional state, hyponatraemia. Escitalopram dosage: 20 Mg Daily Po. During the same period patient was treated with OLANZAPINE (2.5 Mg Twice Daily Po) (View Olanzapine Review and Olanzapine Label ). Patient was hospitalized.

7017949-6 | Aggression, Personality Change
on Aug 10, 2010 Female patient from DENMARK , 33 years of age, was treated with Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, personality change. Escitalopram dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with ANXIOLYTICS (View Anxiolytics Review and Anxiolytics Label ).

7012900-7 | Bipolar Disorder
Patient was taking Escitalopram (View Usage). Patient had the following side effects: bipolar disorder (What is bipolar disorder?) on Sep 09, 2010 from DENMARK Additional patient health information: Female patient , 33 years of age, . Escitalopram dosage: 20 Mg (20 Mg, 1 In 1 D), Oral. During the same period patient was treated with ESCITALOPRAM OXALATE (10 Mg (10 Mg, 1 In 1 D), Oral) (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), MAGNESIUM (MAGNESIUM) (View Magnesium (magnesium) Review and Magnesium (magnesium) Label ).

7009405-6 | Dysphemia, Off Label Use
Adverse event was reported on Sep 09, 2010 by a Female patient taking Escitalopram (View Usage) (Dosage: 20 Mg (20 Mg, 1 In 1 D), Oral) was diagnosed with depression (What is depression?) and. Location: DENMARK , 17 years of age, weighting 176.4 lb, After Escitalopram was administered, patient had the following side effects: dysphemia, off label use. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ATARAX (View Atarax Review and Atarax Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ).

7009398-1 | Off Label Use, Overdose, Suicidal Ideation
on Sep 09, 2010 Female patient from DENMARK , 16 years of age, was treated with Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, overdose, suicidal ideation. Escitalopram dosage: 20 Mg (20 Mg, 1 In 1 D), Oral; 30 Mg (30 Mg, 1 In 1 D), Oral. During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

7009395-6 | Agitation, Hallucination, Auditory, Hallucination, Visual, Paranoia, Psychotic Disorder
on Sep 10, 2010 Female patient from DENMARK , 24 years of age, weighting 119.0 lb, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient had the following side effects: agitation, hallucination, auditory, hallucination, visual, paranoia, psychotic disorder (What is psychotic disorder?). Escitalopram dosage: 5 Mg (5 Mg, 1 In 1 D), Oral.

7009389-0 | Toxic Skin Eruption, Urticaria
Patient was taking Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: toxic skin eruption, urticaria on Sep 08, 2010 from DENMARK Additional patient health information: Male patient , 83 years of age, was diagnosed with depression (What is depression?), cardiovascular event prophylaxis, hypertension, anxiety (What is anxiety?) and. Escitalopram dosage: 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with PREVISCAN (FLUINDIONE) (TABLETS) (5 Mg (5 Mg, 1 In 1 D), Oral) (View Previscan (fluindione) (tablets) Review and Previscan (fluindione) (tablets) Label ), ISRADIPINE (5 Mg (5 Mg, 1 In 1 D), Oral) (View Isradipine Review and Isradipine Label ), URBANYL (CLOBAZAM) (CAPSULES) (5 Mg (5 Mg, 1 In 1 D), Oral) (View Urbanyl (clobazam) (capsules) Review and Urbanyl (clobazam) (capsules) Label ), TADENAN (PRUNUS AFRICANA EXTRACT) (CAPSULES) (100 Mg (50 Mg, 2 In 1 D), Oral) (View Tadenan (prunus Africana Extract) (capsules) Review and Tadenan (prunus Africana Extract) (capsules) Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

7008093-2 | Asthenia, Contusion, Fatigue, Headache, Hyperhidrosis, Hypersomnia, Libido Decreased, Social Phobia, Yawning
Adverse event was reported on Sep 08, 2010 by a Female patient taking Escitalopram (View Usage) (Dosage: 10 Mg (10 Mg, 1 In 1 D), Oral) was diagnosed with depression (What is depression?) and. Location: DENMARK , 35 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, contusion, fatigue, headache (What is headache?), hyperhidrosis, hypersomnia, libido decreased, social phobia, yawning.

7007720-3 | Compulsions, Obsessive-compulsive Disorder
on Sep 07, 2010 Female patient from DENMARK , 61 years of age, was diagnosed with depression (What is depression?), parkinson's disease (What is parkinson's disease?) and was treated with Escitalopram (View Usage). Patient had the following side effects: compulsions, obsessive-compulsive disorder (What is obsessive-compulsive disorder?). Escitalopram dosage: 20 Mg (20 Mg, 1 In 1 D). During the same period patient was treated with RASAGILINE MESYLATE (1 Mg (1 Mg, 1 In 1 D), Oral) (View Rasagiline Mesylate Review and Rasagiline Mesylate Label ), MODOPAR (MADOPAR) (2000 Mg (250 Mg, 8 In 1 D), Oral) (View Modopar (madopar) Review and Modopar (madopar) Label ), PRAMIPEXOLE DIHYDROCHLORIDE (3.15 Mg (3.15 Mg, 1 In 1 D), Oral) (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), COMTAN (1200 Mg (200 Mg, 6 In 1 D)) (View Comtan Review and Comtan Label ). Patient was hospitalized.

7007714-8 | Altered State Of Consciousness, Disturbance In Attention, Fatigue, Off Label Use
on Sep 07, 2010 Male patient from DENMARK , 90 years of age, was diagnosed with suicidal ideation and was treated with Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: altered state of consciousness, disturbance in attention, fatigue, off label use. Escitalopram dosage: 5 Mg (5 Mg, 1 In 1 D),oral.

7005451-7 | Intentional Overdose, Mood Altered, Suicide Attempt
Patient was taking Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: intentional overdose, mood altered, suicide attempt on Sep 07, 2010 from DENMARK Additional patient health information: Female patient , 76 years of age, weighting 105.8 lb, was diagnosed with depression (What is depression?) and. Escitalopram dosage: 5 Mg (5 Mg, 1 In 1 D), Oral. During the same period patient was treated with HYPNOTICS NOS (View Hypnotics Nos Review and Hypnotics Nos Label ), LOXEN (View Loxen Review and Loxen Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), TRIATEC (View Triatec Review and Triatec Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

7005374-3 | Blood Glucose Increased, Blood Pressure Increased, Blood Sodium Decreased, Cardiac Failure, Circulatory Collapse, Fall, Glycosylated Haemoglobin, Glycosylated Haemoglobin Increased
Adverse event was reported on Sep 02, 2010 by a Female patient taking Escitalopram (View Usage) (Dosage: 15 Mg (15 Mg, 1 In 1 D)) . Location: DENMARK , 21 years of age, weighting 251.3 lb, Patient had the following side effects: blood glucose increased, blood pressure increased, blood sodium decreased, cardiac failure, circulatory collapse, fall (What is fall?), glycosylated haemoglobin, glycosylated haemoglobin increased. During the same period patient was treated with FLUANXOL (FLUPENTIXOL) (TABLETS) (0. 5 Mg (0 . 5 Mg, 1 In 1 D),oral) (View Fluanxol (flupentixol) (tablets) Review and Fluanxol (flupentixol) (tablets) Label ), MIANSERIN (MIANSERIN) (10mg (10 Mg, 1 In 1 D)) (View Mianserin (mianserin) Review and Mianserin (mianserin) Label ), NUVARING (NUVARING) (VAGINAL INSERT) (NUVARING) (View Nuvaring (nuvaring) (vaginal Insert) (nuvaring) Review and Nuvaring (nuvaring) (vaginal Insert) (nuvaring) Label ), METFORMIN (METFORMII)(METFORMIN) (View Metformin (metformii)(metformin) Review and Metformin (metformii)(metformin) Label ), NOVORAPID FLEXPEN (INSULIN ASPART) (SOLUTION) (INSULIN ASPART) (View Novorapid Flexpen (insulin Aspart) (solution) (insulin Aspart) Review and Novorapid Flexpen (insulin Aspart) (solution) (insulin Aspart) Label ).

7003518-0 | Blood Pressure Diastolic Decreased, Blood Urea Increased, Bradycardia, Coma, Extrapyramidal Disorder, Fall, Inflammation, Monocyte Count Increased
on Sep 01, 2010 Male patient from DENMARK , 90 years of age, was treated with Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: blood pressure diastolic decreased, blood urea increased, bradycardia, coma, extrapyramidal disorder, fall (What is fall?), inflammation, monocyte count increased. Escitalopram dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with KARDEGIC (ACETYLSALICYLATE LYSINE) (POWDER) (75 Mg (75 Mg, 1 In 1 D), Oral) (View Kardegic (acetylsalicylate Lysine) (powder) Review and Kardegic (acetylsalicylate Lysine) (powder) Label ), LOVENOX (4000 Iu (4000 Iu, 1 In 1 D), Subcutaneous) (View Lovenox Review and Lovenox Label ), AVLOCARDYL (PROPRANOLOL) (TABLETS) (PROPRANOLOL) (View Avlocardyl (propranolol) (tablets) (propranolol) Review and Avlocardyl (propranolol) (tablets) (propranolol) Label ), ARICEPT (DONEPEZIL) (TABLETS) (DONEPEZIL) (View Aricept (donepezil) (tablets) (donepezil) Review and Aricept (donepezil) (tablets) (donepezil) Label ), SERESTA (OXAZEPAM) (TABLETS) (OXAZEPAM) (View Seresta (oxazepam) (tablets) (oxazepam) Review and Seresta (oxazepam) (tablets) (oxazepam) Label ), CETORNAN (ORNITHINE KETOGLUTARATE) (POWDER) (ORNITHINE KETOGLUTARATE) (View Cetornan (ornithine Ketoglutarate) (powder) (ornithine Ketoglutarate) Review and Cetornan (ornithine Ketoglutarate) (powder) (ornithine Ketoglutarate) Label ), FORLAX (MACROGOL) (POWDER) (MACROGOL) (View Forlax (macrogol) (powder) (macrogol) Review and Forlax (macrogol) (powder) (macrogol) Label ), DIFFU K (POTASSIUM CHLORIDE) (POTASSIUM CHLORIDE) (View Diffu K (potassium Chloride) (potassium Chloride) Review and Diffu K (potassium Chloride) (potassium Chloride) Label ). Patient was hospitalized.

7003512-X | Condition Aggravated, Depressive Symptom
on Sep 02, 2010 Female patient from DENMARK , 36 years of age, weighting 143.3 lb, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, depressive symptom. Escitalopram dosage: 5 Mg (5 Mg, 1 In 1 D), Oral; 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ).

7003502-7 | Dizziness, Flushing, Headache, Hot Flush, Hypotension, Loss Of Consciousness, Malaise, Off Label Use, Pallor
Patient was taking Escitalopram (View Usage). Patient had the following side effects: dizziness (What is dizziness?), flushing, headache (What is headache?), hot flush, hypotension, loss of consciousness, malaise, off label use, pallor on Sep 01, 2010 from DENMARK Additional patient health information: Female patient , 30 years of age, weighting 105.8 lb, was diagnosed with depression (What is depression?) and. Escitalopram dosage: 20 Mg (20 Mg, 1 In 1 D), Oral. During the same period patient was treated with ATARAX (View Atarax Review and Atarax Label ), EFFORTIL (ETILEFRINE HYDROCHLORIDE) (ETILEFRINE HYDROCHLORIDE) (View Effortil (etilefrine Hydrochloride) (etilefrine Hydrochloride) Review and Effortil (etilefrine Hydrochloride) (etilefrine Hydrochloride) Label ), IMIGRANE (SUMATRIPTAN) (SUMATRIPTAN) (View Imigrane (sumatriptan) (sumatriptan) Review and Imigrane (sumatriptan) (sumatriptan) Label ), LEVONORGESTREL W/ ETHINYLESTRADIOL(LEVONORGESTREL, ETHINYL ESTRADIOL)( (View Levonorgestrel W/ Ethinylestradiol(levonorgestrel, Ethinyl Estradiol)( Review and Levonorgestrel W/ Ethinylestradiol(levonorgestrel, Ethinyl Estradiol)( Label ), TARDYFERON (TARDYFERON) (TARDYFERON) (View Tardyferon (tardyferon) (tardyferon) Review and Tardyferon (tardyferon) (tardyferon) Label ), TANGANIL (ACETYLLEUCINE) (ACETYLLEUCINE) (View Tanganil (acetylleucine) (acetylleucine) Review and Tanganil (acetylleucine) (acetylleucine) Label ). Patient was hospitalized.

7003490-3 | Bradypnoea, Hypotonia Neonatal
Adverse event was reported on Sep 08, 2010 by a Female patient taking Escitalopram (View Usage) (Dosage: 10 Mg 910 Mg, 1 In 1 D), Transplacental) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: DENMARK , weighting 5.67 lb, After Escitalopram was administered, patient had the following side effects: bradypnoea, hypotonia neonatal. During the same period patient was treated with INVEGA (9 Mg, Transplacental) (View Invega Review and Invega Label ).

6992447-4 | Gestational Trophoblastic Detachment, Metrorrhagia, Pregnancy
on Aug 31, 2010 Female patient from DENMARK , 35 years of age, weighting 123.5 lb, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: gestational trophoblastic detachment, metrorrhagia, pregnancy (What is pregnancy?). Escitalopram dosage: 20 Mg (20 Mg, 1 In 1 D), Oral.

6987735-1 | Psychiatric Evaluation Abnormal
on Aug 30, 2010 Female patient from DENMARK , 68 years of age, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient had the following side effects: psychiatric evaluation abnormal. Escitalopram dosage: 10 Mg (10 Mg, 1 In 1 D), Oral.

6986096-1 | Bradypnoea, Hypotonia Neonatal
Patient was taking Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: bradypnoea, hypotonia neonatal on Aug 25, 2010 from DENMARK Additional patient health information: Female patient , weighting 5.67 lb, . Escitalopram dosage: 10 Mg (10 Mg, 1 In 1 D) Transplacental. During the same period patient was treated with INVEGA (View Invega Review and Invega Label ).

6986095-X | Psychiatric Evaluation Abnormal
Adverse event was reported on Aug 26, 2010 by a Male patient taking Escitalopram (View Usage) (Dosage: 10 Mg (10 Mg, 1 In 1 D), Oral) was diagnosed with depression (What is depression?) and. Location: DENMARK , 26 years of age, Patient experienced the following unwanted or unexpected effects: psychiatric evaluation abnormal.

6985733-5 | Compulsive Shopping
on Aug 31, 2010 Female patient from DENMARK , 69 years of age, was treated with Escitalopram (View Usage). Patient had the following side effects: compulsive shopping. Escitalopram dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with TEMESTA (View Temesta Review and Temesta Label ), LEXOMIL (View Lexomil Review and Lexomil Label ).

6985722-0 | Disinhibition, Gun Shot Wound, Suicide Attempt
on Aug 27, 2010 Male patient from DENMARK , 67 years of age, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: disinhibition, gun shot wound, suicide attempt. Escitalopram dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PLAVIX (View Plavix Review and Plavix Label ), LYSANXIA (View Lysanxia Review and Lysanxia Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

6985699-8 | Investigation Abnormal
Patient was taking Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: investigation abnormal on Aug 27, 2010 from DENMARK Additional patient health information: Male patient , 28 years of age, was diagnosed with depression (What is depression?) and. Escitalopram dosage: 5 Mg (5 Mg, 1 In 1 D), Oral; 10 Mg (10 Mg, 1 In 1 D), Oral.

6980471-7 | Asthenia, Dyskinesia, Fatigue, Sleep Disorder
Adverse event was reported on Aug 26, 2010 by a Female patient taking Escitalopram (View Usage) (Dosage: 5 To 15 Mg Per Day (1 In 1 D),oral) was diagnosed with burnout syndrome, depression (What is depression?) and. Location: DENMARK , 36 years of age, Patient had the following side effects: asthenia, dyskinesia, fatigue, sleep disorder (What is sleep disorder?). Patient was hospitalized.

6980470-5 | Dyskinesia, Erectile Dysfunction, Paraesthesia
on Aug 31, 2010 Male patient from DENMARK , 74 years of age, weighting 172.0 lb, was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and was treated with Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: dyskinesia, erectile dysfunction (What is erectile dysfunction?), paraesthesia. Escitalopram dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), VASTAREL (View Vastarel Review and Vastarel Label ), ATARAX (View Atarax Review and Atarax Label ), TRANSIPEG (View Transipeg Review and Transipeg Label ).

6979685-1 | Mental Disorder
on Aug 24, 2010 Male patient from DENMARK , 40 years of age, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: mental disorder. Escitalopram dosage: 20 Mg (20 Mg, 1 In 1 D), Oral.

6979682-6 | Blood Osmolarity Decreased, Fall, Hyponatraemia, Psychomotor Retardation
Patient was taking Escitalopram (View Usage). Patient had the following side effects: blood osmolarity decreased, fall (What is fall?), hyponatraemia, psychomotor retardation on Aug 24, 2010 from DENMARK Additional patient health information: Female patient , 89 years of age, . Escitalopram dosage: 20 Mg (20 Mg, 1 In 1 D), Oral. During the same period patient was treated with LASIX (20 Mg (20 Mg, 1 In 1 D), Oral) (View Lasix Review and Lasix Label ), NEXIUM (View Nexium Review and Nexium Label ), CORDARONE (View Cordarone Review and Cordarone Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), EQUANIL (View Equanil Review and Equanil Label ), ATACAND (View Atacand Review and Atacand Label ), PARIET (View Pariet Review and Pariet Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6973975-4 | Anaemia, Haemorrhagic Disorder
Adverse event was reported on Aug 23, 2010 by a Female patient taking Escitalopram (View Usage) (Dosage: 10 Mg (10 Mg, 1 In 1 D), Oral) was diagnosed with depression (What is depression?) and. Location: DENMARK , 92 years of age, weighting 70.55 lb, After Escitalopram was administered, patient had the following side effects: anaemia, haemorrhagic disorder. During the same period patient was treated with ARIXTRA (2.5 Mg / 0.5 Ml (1 Dosage Forms), Subcutaneous) (View Arixtra Review and Arixtra Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FOSAVANCE (View Fosavance Review and Fosavance Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ). Patient was hospitalized.

6973028-5 | Acute Pulmonary Oedema
on Aug 24, 2010 Female patient from DENMARK , 85 years of age, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema. Escitalopram dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. Patient was hospitalized.

6970099-7 | Anxiety, Dyskinesia, Erectile Dysfunction, Paraesthesia
on Aug 19, 2010 Male patient from DENMARK , 74 years of age, weighting 172.0 lb, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient had the following side effects: anxiety (What is anxiety?), dyskinesia, erectile dysfunction (What is erectile dysfunction?), paraesthesia. Escitalopram dosage: 10 Mg (10 Mg, 1 In 1 D) Oral. During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), VASTAREL (View Vastarel Review and Vastarel Label ).

6970092-4 | Completed Suicide, Drowning, Road Traffic Accident
Patient was taking Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: completed suicide, drowning (What is drowning?), road traffic accident on Aug 19, 2010 from DENMARK Additional patient health information: Female patient , 66 years of age, was diagnosed with depression (What is depression?) and. Escitalopram dosage: 20 Mg (20 Mg, 1 In 1 D) Oral. During the same period patient was treated with VALDOXAN (25 Mg (25 Mg, 1 In 1 D)) (View Valdoxan Review and Valdoxan Label ), RIVOTRIL (TABLETS) (View Rivotril (tablets) Review and Rivotril (tablets) Label ), NEXIUM (View Nexium Review and Nexium Label ), SECTRAL (View Sectral Review and Sectral Label ), REFRESCH COLLYRE (EYE DROPS) (View Refresch Collyre (eye Drops) Review and Refresch Collyre (eye Drops) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

6970089-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Lymphocyte Count Increased, Neutrophil Count Increased, Renal Failure Acute
Adverse event was reported on Aug 18, 2010 by a Female patient taking Escitalopram (View Usage) (Dosage: Oral) . Location: DENMARK , 73 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, lymphocyte count increased, neutrophil count increased, renal failure acute. During the same period patient was treated with PREVISCAN (20 MILLIGRAM) (Oral) (View Previscan (20 Milligram) Review and Previscan (20 Milligram) Label ), VALSARTAN AND HYDROCHLOROTHIAZIDE (Oral) (View Valsartan And Hydrochlorothiazide Review and Valsartan And Hydrochlorothiazide Label ), PARIET (Oral) (View Pariet Review and Pariet Label ), MOTILIUM (Oral) (View Motilium Review and Motilium Label ), GAVISCON (Oral) (View Gaviscon Review and Gaviscon Label ), TAHOR (View Tahor Review and Tahor Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TEMERIT (View Temerit Review and Temerit Label ). Patient was hospitalized.

6970076-6 | Affective Disorder, Suicidal Ideation
on Aug 20, 2010 Male patient from DENMARK , 37 years of age, weighting 218.3 lb, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). Patient had the following side effects: affective disorder, suicidal ideation. Escitalopram dosage: 100 Mg (10 Mg, 1 In 1 D) Oral. Patient was hospitalized.

6969424-2 | Cerebral Infarction, Depression, Mitral Valve Prolapse
on Aug 19, 2010 Male patient from DENMARK , 39 years of age, was diagnosed with depression (What is depression?) and was treated with Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: cerebral infarction, depression (What is depression?), mitral valve prolapse. Escitalopram dosage: 20 Mg (20 Mg), Oral. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

6969381-9 | Psychiatric Evaluation Abnormal
Patient was taking Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: psychiatric evaluation abnormal on Aug 18, 2010 from DENMARK Additional patient health information: Female patient , 36 years of age, was diagnosed with depression (What is depression?) and. Escitalopram dosage: 5 Mg (5 Mg, 1 In 1 D), Oral; 10 Mg (10 Mg, 1 In 1 D), Oral.

6969379-0 | Anger, Anxiety, Compulsions, Condition Aggravated, Confusional State, Dizziness, Insomnia, Mania
Adverse event was reported on Aug 18, 2010 by a Male patient taking Escitalopram (View Usage) (Dosage: 10 Mg (10 Mg, 1 In 1 D), Oral) . Location: DENMARK , 62 years of age, weighting 164.9 lb, Patient had the following side effects: anger, anxiety (What is anxiety?), compulsions, condition aggravated, confusional state, dizziness (What is dizziness?), insomnia, mania.

6967631-6 | Agoraphobia, Anxiety, Depressed Mood, Dizziness, Dry Mouth, Eating Disorder, Insomnia, Loss Of Libido, Malaise
on Aug 17, 2010 Male patient from DENMARK , 48 years of age, was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and was treated with Escitalopram (View Usage). After Escitalopram was administered, patient had the following side effects: agoraphobia, anxiety (What is anxiety?), depressed mood, dizziness (What is dizziness?), dry mouth, eating disorder (What is eating disorder?), insomnia, loss of libido, malaise. Escitalopram dosage: Oral. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), NEOCLARITYN (View Neoclarityn Review and Neoclarityn Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ).

6967600-6 | Constipation, Depression, Dizziness, Dry Mouth, Erection Increased, Increased Appetite, Muscular Weakness, Nausea, Somnolence
on Aug 18, 2010 Male patient from DENMARK , 56 years of age, weighting 229.9 lb, was treated with Escitalopram (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), depression (What is depression?), dizziness (What is dizziness?), dry mouth, erection increased, increased appetite, muscular weakness, nausea (What is nausea?), somnolence. Escitalopram dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with CLONAZEPAM (1 Mg (1 Mg, 1 In 1 D), Oral) (View Clonazepam Review and Clonazepam Label ), SEROQUEL (200 Mg (200 Mg, 1 In 1 D), Oral) (View Seroquel Review and Seroquel Label ), WELLBUTRIN XL (TALBETS) (300 Mg (300 Mg, 1 In 1 D), Oral) (View Wellbutrin Xl (talbets) Review and Wellbutrin Xl (talbets) Label ), ECHINACEA (View Echinacea Review and Echinacea Label ), HORSE CHESTNUT EXTRACT (View Horse Chestnut Extract Review and Horse Chestnut Extract Label ), MILK THISTLE (View Milk Thistle Review and Milk Thistle Label ).

6967572-4 | Muscle Haemorrhage
Patient was taking Escitalopram (View Usage). Patient had the following side effects: muscle haemorrhage on Aug 18, 2010 from DENMARK Additional patient health information: Male patient , 64 years of age, . Escitalopram dosage: 20 Mg (20 Mg, 1 In 1 D), Oral. During the same period patient was treated with KARDEGIC (Oral) (View Kardegic Review and Kardegic Label ), VICTOZA (2000 Iu Internation Units (1000 Iu,2 In 1 D), Subcutaneous) (View Victoza Review and Victoza Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), GLUCOR (View Glucor Review and Glucor Label ), JANUVIA (View Januvia Review and Januvia Label ). Patient was hospitalized.